Cite
FDA wants more disclosure of gene-therapy and xenotransplantation risks.
MLA
McCarthy, Michael. “FDA Wants More Disclosure of Gene-Therapy and Xenotransplantation Risks.” Lancet, vol. 357, no. 9252, Jan. 2001, p. 292. EBSCOhost, https://doi.org/10.1016/S0140-6736(05)71741-4.
APA
McCarthy, M. (2001). FDA wants more disclosure of gene-therapy and xenotransplantation risks. Lancet, 357(9252), 292. https://doi.org/10.1016/S0140-6736(05)71741-4
Chicago
McCarthy, Michael. 2001. “FDA Wants More Disclosure of Gene-Therapy and Xenotransplantation Risks.” Lancet 357 (9252): 292. doi:10.1016/S0140-6736(05)71741-4.